Digitalis glycosides could safely prevent worsening heart failure events

Digitalis glycosides may be a safe and tolerable addition to optimal guideline medical therapy to reduce worsening heart failure events in patients with HF with mildly reduced or reduced ejection fraction, researchers reported.Despite recent data from the DECISION study showing digoxin did not reduce the composite endpoint of HF outcomes and mortality, a meta-analysis presented at Heart Failure